Clinical Trials | An observational study in patients with indolent systemic mastocytosis
An observational study in patients with indolent systemic mastocytosis / BLU-285-2406
The University of Virginia Cancer Center is conducting a clinical research study for patients who are adults ages 18 and over, and have been diagnosed with indolent systemic mastocytosis (ISM). The purpose of this study is to look at how people with ISM are doing in their everyday lives. This study will observe their symptoms, their quality of life, and their treatment for ISM. Participation includes a screening period, 1 clinic visit every 6 months for 5 years, and completing electronic questionnaires every 3 months. Any study specific tests will be provided at no cost to you. Additional information can be found here: https://clinicaltrials.gov/study/NCT07264959 Contact= [email protected]